Anand Agneshwar co-chairs the firm’s Product Liability Litigation practice group. Mr. Agneshwar represents pharmaceutical and consumer product companies as national, strategic, trial, and appellate counsel in product liability litigation and related litigation. His experience includes bench and jury trials, numerous bench hearings, and hundreds of significant arguments in state and federal trial and appellate courts across the country. He is recognized nationwide for his courtroom presence and strategic acumen and was the architect of the personal jurisdiction theory that ultimately prevailed in Bristol-Myers Squibb Co. v. Superior Court of California. He counsels clients on litigation risks, US Food and Drug Administration (FDA) regulatory issues, and the litigation and compliance impact of potential legislation. Mr. Agneshwar writes frequently on product liability and FDA issues. He maintains an active pro bono practice focusing on protecting civil liberties and chairs the firm’s Diversity & Inclusion Committee.